Rosh Dias, M.D., M.R.C.P
2021
In 2021, Rosh Dias, M.D., M.R.C.P earned a total compensation of $1.1M as Former Chief Medical Officer at SPRUCE BIOSCIENCES, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $43,000 |
|---|---|
| Option Awards | $583,014 |
| Salary | $430,000 |
| Stock Awards | $49,600 |
| Total | $1,105,614 |
MRCP received $583K in option awards, accounting for 53% of the total pay in 2021.
MRCP also received $43K in non-equity incentive plan, $430K in salary and $49.6K in stock awards.
Rankings
In 2021, Rosh Dias, M.D., M.R.C.P's compensation ranked 8,442nd out of 12,406 executives tracked by ExecPay. In other words, MRCP earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,442 out of 12,406 | 32nd |
Division Manufacturing | 3,733 out of 5,492 | 32nd |
Major group Chemicals And Allied Products | 1,653 out of 2,368 | 30th |
Industry group Drugs | 1,471 out of 2,089 | 30th |
Industry Pharmaceutical Preparations | 1,095 out of 1,536 | 29th |
Source: SEC filing on April 7, 2022.
MRCP's colleagues
We found three more compensation records of executives who worked with Rosh Dias, M.D., M.R.C.P at SPRUCE BIOSCIENCES in 2021.